Episurf Medical AB (publ) (FRA:16E)
Germany
· Delayed Price · Currency is EUR 0.0001
-0.0010 (-90.91%)
At close: Dec 4, 2025
Episurf Medical AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 21.4 | 20.6 | 19.8 | 6.6 | 6.5 | 5 | Upgrade
|
| Revenue | 21.4 | 20.6 | 19.8 | 6.6 | 6.5 | 5 | Upgrade
|
| Revenue Growth (YoY) | 12.63% | 4.04% | 200.00% | 1.54% | 30.00% | 2.04% | Upgrade
|
| Cost of Revenue | 52.4 | 52.4 | 61.6 | 36.2 | 35 | 34.5 | Upgrade
|
| Gross Profit | -31 | -31.8 | -41.8 | -29.6 | -28.5 | -29.5 | Upgrade
|
| Selling, General & Admin | 36 | 36.5 | 46.6 | 40.3 | 34 | 28.8 | Upgrade
|
| Other Operating Expenses | -12.7 | -0.1 | -0.3 | -0.3 | -0.4 | -0.5 | Upgrade
|
| Operating Expenses | 31.8 | 45.4 | 55 | 47.4 | 41 | 35.9 | Upgrade
|
| Operating Income | -62.8 | -77.2 | -96.8 | -77 | -69.5 | -65.4 | Upgrade
|
| Interest Expense | -0.7 | -1 | -0.9 | -0.7 | -0.2 | -0.7 | Upgrade
|
| Interest & Investment Income | 1.2 | 2.2 | 3.1 | 0.5 | 0.4 | 0.1 | Upgrade
|
| Other Non Operating Income (Expenses) | - | 0.1 | 0.1 | - | -0.1 | 0.1 | Upgrade
|
| EBT Excluding Unusual Items | -62.3 | -75.9 | -94.5 | -77.2 | -69.4 | -65.9 | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.1 | 2 | Upgrade
|
| Pretax Income | -62.3 | -75.9 | -94.5 | -77.2 | -69.3 | -63.9 | Upgrade
|
| Income Tax Expense | 0.5 | 0.1 | 0.3 | 0.1 | - | - | Upgrade
|
| Net Income | -62.8 | -76 | -94.8 | -77.3 | -69.3 | -63.9 | Upgrade
|
| Net Income to Common | -62.8 | -76 | -94.8 | -77.3 | -69.3 | -63.9 | Upgrade
|
| Shares Outstanding (Basic) | 771 | 495 | 314 | 267 | 227 | 162 | Upgrade
|
| Shares Outstanding (Diluted) | 771 | 495 | 314 | 267 | 227 | 162 | Upgrade
|
| Shares Change (YoY) | 95.30% | 57.49% | 17.84% | 17.67% | 39.80% | 140.68% | Upgrade
|
| EPS (Basic) | -0.08 | -0.15 | -0.30 | -0.29 | -0.31 | -0.39 | Upgrade
|
| EPS (Diluted) | -0.08 | -0.15 | -0.30 | -0.29 | -0.31 | -0.39 | Upgrade
|
| Free Cash Flow | -56.5 | -71.4 | -84.8 | -69.5 | -59.8 | -54.1 | Upgrade
|
| Free Cash Flow Per Share | -0.07 | -0.14 | -0.27 | -0.26 | -0.26 | -0.33 | Upgrade
|
| Gross Margin | -144.86% | -154.37% | -211.11% | - | - | - | Upgrade
|
| Operating Margin | -293.46% | -374.76% | -488.89% | -1166.67% | -1069.23% | -1308.00% | Upgrade
|
| Profit Margin | -293.46% | -368.93% | -478.79% | -1171.21% | -1066.15% | -1278.00% | Upgrade
|
| Free Cash Flow Margin | -264.02% | -346.60% | -428.28% | -1053.03% | -920.00% | -1082.00% | Upgrade
|
| EBITDA | -62.1 | -74.1 | -94.1 | -74.4 | -66.6 | -62.5 | Upgrade
|
| D&A For EBITDA | 0.7 | 3.1 | 2.7 | 2.6 | 2.9 | 2.9 | Upgrade
|
| EBIT | -62.8 | -77.2 | -96.8 | -77 | -69.5 | -65.4 | Upgrade
|
| Revenue as Reported | 20.7 | 20.7 | 20.1 | 18.2 | 13.8 | 7 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.